Daptomycin vs Polymyxin B — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Daptomycin (Cubicin) is a cyclic lipopeptide antibiotic from Streptomyces roseosporus, FDA-approved in 2003. It has a novel mechanism of action distinct from all other approved antibiotics: calcium-dependent insertion into bacterial membranes followed by channel formation and rap...
Calculate Daptomycin dose →Polymyxin B is a cyclic lipopeptide antibiotic from Bacillus polymyxa that was approved in the 1960s and fell out of favor due to nephrotoxicity, but has experienced a major clinical resurgence as a last-resort treatment for carbapenem-resistant Gram-negative infections (Acinetob...
Calculate Polymyxin B dose →| Parameter | Daptomycin | Polymyxin B |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | FDA Approved |
| Half-Life | 8-9 hours | 6-8 hours |
| Typical Dose | 4-6 mg/kg IV once daily (skin); 6-10 mg/kg IV once daily (bacteremia) | 15,000-25,000 units/kg/day IV |
| Frequency | Once daily IV | Every 12 hours IV |
| Route | IV | IV / IM / Topical / Intrathecal |
| FDA Status | Approved (MRSA skin, bacteremia, right-sided endocarditis, 2003) | Approved (systemic Gram-negative infections) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.